[HTML][HTML] Radiation induced secondary malignancies: a review article
CB Dracham, A Shankar, R Madan - Radiation oncology journal, 2018 - ncbi.nlm.nih.gov
Radiation-induced second malignancies (RISM) is one of the important late side effects of
radiation therapy and has an impact on optimal treatment decision-making. Many factors …
radiation therapy and has an impact on optimal treatment decision-making. Many factors …
Intensity-modulated radiation therapy, protons, and the risk of second cancers
EJ Hall - International Journal of Radiation Oncology* Biology …, 2006 - Elsevier
Intensity-modulated radiation therapy (IMRT) allows dose to be concentrated in the tumor
volume while sparing normal tissues. However, the downside to IMRT is the potential to …
volume while sparing normal tissues. However, the downside to IMRT is the potential to …
World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs
TY Chan - Urology, 2005 - goldjournal.net
This 2004 volume in the World Health Organization series on histologic and genetic typing
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
Solid cancer incidence in atomic bomb survivors: 1958–1998
DL Preston, E Ron, S Tokuoka… - Radiation …, 2007 - meridian.allenpress.com
Abstract Preston, DL, Ron, E., Tokuoka, S., Funamoto, S., Nishi, N., Soda, M., Mabuchi, K.
and Kodama, K. Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998. Radiat …
and Kodama, K. Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998. Radiat …
Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987
DL Preston, S Kusumi, M Tomonaga… - Radiation …, 1994 - meridian.allenpress.com
This paper presents an analysis of data on the incidence of leukemia, lymphoma and
myeloma in the Life Span Study cohort of atomic bomb survivors during the period from late …
myeloma in the Life Span Study cohort of atomic bomb survivors during the period from late …
Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries
AB De Gonzalez, RE Curtis, SF Kry, E Gilbert… - The lancet …, 2011 - thelancet.com
Background Improvements in cancer survival have made the long-term risks from treatments
more important, including the risk of developing a second cancer after radiotherapy. We …
more important, including the risk of developing a second cancer after radiotherapy. We …
Second cancers among 40 576 testicular cancer patients: focus on long-term survivors
LB Travis, SD Fosså, SJ Schonfeld… - Journal of the …, 2005 - academic.oup.com
Background: Although second primary cancers are a leading cause of death among men
with testicular cancer, few studies have quantified risks among long-term survivors. Methods …
with testicular cancer, few studies have quantified risks among long-term survivors. Methods …
Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987
DE Thompson, K Mabuchi, E Ron… - Radiation …, 1994 - meridian.allenpress.com
This report presents, for the first time, comprehensive data on the incidence of solid cancer
and risk estimates for A-bomb survivors in the extended Life Span Study (LSS-E85) cohort …
and risk estimates for A-bomb survivors in the extended Life Span Study (LSS-E85) cohort …
Second malignant neoplasms: assessment and strategies for risk reduction
ME Wood, V Vogel, A Ng, L Foxhall… - Journal of clinical …, 2012 - ascopubs.org
Improvements in early detection, supportive care, and treatment have resulted in an
increasing number of cancer survivors, with a current 5-year relative survival rate for all …
increasing number of cancer survivors, with a current 5-year relative survival rate for all …
Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery
DJ Brenner, RE Curtis, EJ Hall… - … International Journal of …, 2000 - Wiley Online Library
BACKGROUND In the treatment of prostate carcinoma, radiotherapy and surgery are
common choices of comparable efficacy; thus a realistic comparison of the potential long …
common choices of comparable efficacy; thus a realistic comparison of the potential long …